Delivery of contrast agents for positron emission tomography imaging by liposomes

Advanced Drug Delivery Reviews

Volumn 37, Issue 1-3, 1999, Pages 53-61

  Oku, Naoto ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

Liposomes; Long circulating liposomes; Positron emission tomography; Tumor imaging; Tumor metastasis

Indexed keywords

CELL MEMBRANES; COMPUTER AIDED ANALYSIS; DIAGNOSTIC RADIOGRAPHY; ENCAPSULATION; LIPIDS; POSITRON EMISSION TOMOGRAPHY; REAL TIME SYSTEMS;

CONTRAST AGENTS; LIPOSOMES; LONG CIRCULATING LIPOSOMES; TUMOR IMAGING; TUMOR METASTASIS;

CONTROLLED DRUG DELIVERY;

BROMIDE; CONTRAST MEDIUM; DIPALMITOYLPHOSPHATIDYLCHOLINE; DIPALMITOYLPHOSPHATIDYLGLYCEROL; FLUORODEOXYGLUCOSE F 18; GANGLIOSIDE GM1; GLUCURONIDE; LIPOSOME; MACROGOL; OCTADECYLAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; DIAGNOSTIC IMAGING; DRUG ACETYLATION; DRUG DELIVERY SYSTEM; DRUG DNA BINDING; DRUG SCREENING; DRUG TARGETING; ELECTRICITY; ENCAPSULATION; EXTRAVASATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER; MALE; METASTASIS; MOUSE; NONHUMAN; PARTICLE SIZE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; REVIEW; SPLEEN; TUMOR;

EID: 0345390164     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(98)00110-0     Document Type: Review

References (24)

1. A. Kubo, K. Nakamura, T. Sammiya, M. Katayama, T. Hashimoto, S. Hashimoto, H. Kobayashi, T. Teramoto, Indium-111-labelled liposomes: dosimetry and tumour detection in patients with cancer, Eur. J. Nucl. Med. 20 (1993) 107-113.
2. I. Ogihara-Umeda, T. Sasaki, S. Kojima, H. Nishigori, Optimal radiolabeled liposomes for tumor imaging, J. Nucl. Med. 37 (1996) 326-332.
3. B. Goins, W.T. Phillips, R. Klipper, Blood-pool imaging using technetium-99m-labeled liposomes, J. Nucl. Med. 37 (1996) 1374-1379.
4. C. Tilcock, Liposomal blood pool agents for nuclear medicine and magnetic resonance imaging, J. Liposome Res. 4 (1994) 909-936.
5. K. Nakamura, A. Kubo, M. Katayama, Indium-111-labeled liposomes: quality and biodistribution in mice bearing human tumor xenografts, Drug Deliv. 1 (1993) 69-73.
6. C.A. Presant, A.F. Turner, R.T. Proffitt, Potential for improvement in clinical decision-making: tumor imaging with In-111 labeled liposomes. Results of a Phase II-III study, J. Liposome Res. 4 (1994) 985-1008.
7. A. Gabizon, D.C. Price, J. Huberty, R.S. Bresalier, D. Papahadjopoulos, Effect of liposome composition and other factors on the targeting of liposomes to experimental tumors: biodistribution and imaging studies, Cancer Res. 50 (1990) 6371-6378.
8. T.M. Allen, A. Chonn, Large unilamellar liposomes with low uptake into the reticuloendothelial system, FEBS Lett. 223 (1987) 42-46.
9. Y. Namba, T. Sakakibara, M. Masada, F. Ito, N. Oku, Glucuronate-modified liposomes with long half lives in vivo, Chem. Pharm. Bull. 38 (1990) 1663-1666.
10. N. Oku, Y. Namba, S. Okada, Tumor accumulation of novel RES-avoiding liposomes, Biochim. Biophys. Acta 1126 (1992) 255-260.
11. G. Blume, G. Cevc, Liposomes for the sustained drug release in vivo, Biochim. Biophys. Acta 1029 (1990) 91-97.
12. A.L. Klibanov, K. Maruyama, V.P. Torchilin, L. Huang, Amphiphathic polyethyleneglycols effectively prolong the circulation time of liposomes, FEBS Lett. 268 (1990) 235-237.
13. T.M. Allen, C. Hansen, F. Martin, C. Redemann, A. Yan-Young, Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo, Biochim. Biophys. Acta 1066 (1991) 29-36.
14. G.E. Francis, C. Delgado, D. Fisher, F. Malik, A.K. Agrawal, Polyethylene glycol modification: relevance of improved methodology to tumour targeting, J. Drug Target. 3 (1996) 321-340.
15. M.C. Woodle, 67Gallim-labeled liposomes with prolonged circulation: preparation and potential as nuclear imaging agnets, Nucl. Med. Biol. 20 (1993) 149-155.
16. N. Oku, Y. Namba, A. Takeda, S. Okada, Tumor imaging with technetium-99m-DTPA encapsulated in RES-avoiding liposomes, Nucl. Med. Biol. 20 (1993) 407-412.
17. N. Oku, Y. Tokudome, H. Tsukada, S. Okada, Real-time analysis of liposomal trafficking in tumor-bearing mice by use of positron emission tomography, Biochim. Biophys. Acta 1238 (1995) 86-90.
18. D. Liu, A. Mori, L. Huang, Role of liposome size and RES blockade in controlling biodistribution and tumor uptake of GM1-containing liposomes, Biochim. Biophys. Acta 1104 (1992) 95-101.
19. D.C. Litzinger, A.M. Buiting, N. van Rooijen, L. Huang, Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes, Biochim. Biophys. Acta 1190 (1994) 99-107.
20. N. Oku, Y. Tokudome, H. Tsukada, T. Kosugi, Y. Namba, S. Okada, In vivo trafficking of long-circulating liposomes in tumour-bearing mice determined by positron emission tomography, Biopharm. Drug Dispos. 17 (1996) 435-441.
21. K. Yang, G.L. Clifton, R.L. Hayes, Gene therapy for central nervous system injury: the use of cationic liposomes, J. Neurotrauma 14 (1997) 281-297.
22. R.J. Lee, L. Huang, Lipidic vector systems for gene transfer, Crit. Rev. Ther. Drug Carrier Syst. 14 (1997) 173-206.
23. N. Oku, Y. Tokudome, Y. Namba, N. Saito, M. Endo, Y. Hasegawa, M. Kawai, H. Tsukada, S. Okada, Effect of serum protein binding on real-time trafficking of liposomes with different charges analyzed by positron emission tomography, Biochim. Biophys. Acta 1280 (1996) 149-154.
24. A. Chonn, P.R. Cullis, D.V. Devine, The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes, J. Immunol. 146 (1991) 4234-4241.